Analytical Results.
Supporting information, where available.
Documentation is product-specific.
Analytical results are shown only for products with suitable supporting documentation. Availability varies by product.
Epithalon 10 mg
| Epithalon result | 10.90 mg |
|---|---|
| Purity | 99.819% |
Charts summarise the recorded values above.
These results do not represent testing performed by XAVEXRA LABS.
Research use only / Not for human consumption.
View Epithalon 10 mgPT-141 10 mg
| PT-141 result | 10.96 mg |
|---|---|
| Purity | 99.859% |
| Analysis date | 06 March 2026 |
Charts summarise the recorded values above.
These results do not represent testing performed by XAVEXRA LABS.
Research use only / Not for human consumption.
View PT-141 10 mgGlutathione 1500 mg
| Glutathione result | 1449.86 mg |
|---|---|
| Purity | 99.99% |
Charts summarise the recorded values above.
These results do not represent testing performed by XAVEXRA LABS.
Research use only / Not for human consumption.
View Glutathione 1500 mgSS-31 10 mg
| SS-31 result | 10.53 mg |
|---|---|
| Purity | 99.82% |
Charts summarise the recorded values above.
These results do not represent testing performed by XAVEXRA LABS.
Research use only / Not for human consumption.
View SS-31 10 mgAOD-9604 5 mg
| AOD-9604 result | 7.19 mg |
|---|---|
| Purity | 99.89% |
Charts summarise the recorded values above.
These results do not represent testing performed by XAVEXRA LABS.
Research use only / Not for human consumption.
View AOD-9604 5 mgTesamorelin 10 mg
| Chromatographic purity | 99.47% |
|---|---|
| Total peptide mass | 9.78 mg |
| Identity | Confirmed by HPLC-UV/MS |
Charts summarise the recorded values above.
These results do not represent testing performed by XAVEXRA LABS.
Research use only / Not for human consumption.
View Tesamorelin 10 mgTB-500 10 mg
| Compound identity | TB-500 (TB-4) |
|---|---|
| Chromatographic purity | 99.748% |
| Labelled content | 10 mg |
| Measured peptide content | 11.77 mg |
Charts summarise the recorded values above.
These results do not represent testing performed by XAVEXRA LABS.
Research use only / Not for human consumption.
View TB-500 10 mgRetatrutide 40 mg
| Chromatographic purity | 99.8% |
|---|---|
| Labelled content | 40 mg |
| Measured potency/content | 45.3 mg |
| Measured content relative to label (rounded) | 113.3% |
Charts summarise the recorded values above.
These results do not represent testing performed by XAVEXRA LABS.
Research use only / Not for human consumption.
View Retatrutide 40 mgKPV 10 mg
| Chromatographic purity | 99.44% |
|---|---|
| Labelled content | 10 mg |
| Measured peptide content | 9.72 mg |
Charts summarise the recorded values above.
These results do not represent testing performed by XAVEXRA LABS.
Research use only / Not for human consumption.
View KPV 10 mgMOTS-C 10 mg
| Chromatographic purity | 99.087% |
|---|---|
| Labelled content | 10 mg |
| Measured peptide content | 11.47 mg |
Charts summarise the recorded values above.
These results do not represent testing performed by XAVEXRA LABS.
Research use only / Not for human consumption.
View MOTS-C 10 mgKLOW 80 mg
| GHK-Cu measured content | 55.81 mg |
|---|---|
| BPC-157 measured content | 11.17 mg |
| TB-500 (TB4) measured content | 10.51 mg |
| KPV measured content | 11.49 mg |
| Total labelled content | 80 mg |
| Total measured content | 88.98 mg |
| Analysis date | 30 March 2026 |
Charts summarise the recorded values above.
These results do not represent testing performed by XAVEXRA LABS.
Research use only / Not for human consumption.
View KLOW 80 mgSemax 10 mg
| Chromatographic purity | 99.74% |
|---|---|
| Measured peptide content | 11.76 mg |
Charts summarise the recorded values above.
These results do not represent testing performed by XAVEXRA LABS.
Research use only / Not for human consumption.
View Semax 10 mg